NCT03866785

Brief Summary

Prostate cancer is the most common cancer in France (56,841 cases in 2012). Although the benefits of physical activity (PA) in cancer patients are currently well established in the scientific literature, several studies have shown that this population is not sufficiently active. Strengthen patient adherence to prevention counseling by the physical activity (PA) is emerging as a new challenge for personalized treatment in oncology. In order to encourage the engagement and maintenance in a regular PA of cancer patients, first, their experiences of physical activity (PA) practice should be considered and their initial social representations of the practice considered. Secondarily, it is also important to identify health professionals who retain a key role in defining the framework, objectives and means of action to promote lifestyle changes towards a more active lifestyle. In addition, peer mentoring appears to offer promising perspectives for promoting adherence and long-term maintenance in physical activity (PA) of cancer patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 2, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 22, 2018

Completed
5 months until next milestone

First Posted

Study publicly available on registry

March 7, 2019

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 14, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 14, 2021

Completed
Last Updated

February 8, 2023

Status Verified

February 1, 2023

Enrollment Period

3.1 years

First QC Date

October 22, 2018

Last Update Submit

February 7, 2023

Conditions

Keywords

Prostate cancerPhysical activityActivity actigraphPeerProgramSports medicine

Outcome Measures

Primary Outcomes (1)

  • Physical Activity sessions performed

    Analysis of the proportion (%) of Physical Activity sessions performed after 3 months of intervention.

    At month 3

Secondary Outcomes (6)

  • physical activity via activity actigraph

    At month 3

  • sedentary lifestyle via activity actigraph

    At month 3

  • Patient's activation

    At month 3

  • brakes blocking intervention

    At month 3

  • levers favoring intervention

    At month 3

  • +1 more secondary outcomes

Study Arms (3)

STEP 1: Patient with prostate cancer

OTHER

First, patients with prostate cancer will be included during step 1. They will have an interview.

Diagnostic Test: interview

STEP 2: Patient with prostate cancer and a physical activity

OTHER

Secondly, patient with prostate cancer and a physical activity will be included during step 2. They are called "peer". They will have a questionnaire Adult Physical Activity Questionnaire (APAQ), an activity actigraph and a peer training. The peer will help patients to realize the Physical Activity Program during step 3.

Diagnostic Test: Adult Physical Activity Questionnaire (APAQ)Device: Activity actigraphOther: Peer training

STEP 3: Physical Activity Program

OTHER

Finally, patients with prostate cancer (different from step 1) and who agrees to participate at the Physical Activity Program will be included during step 3. They will have an activity actigraph and a questionnaire Adult Physical Activity Questionnaire (APAQ) at inclusion and 3 months later. They will receive the Physical Activity Program.

Diagnostic Test: Adult Physical Activity Questionnaire (APAQ)Device: Activity actigraphOther: Physical Activity Program

Interventions

interviewDIAGNOSTIC_TEST

The goal is to evaluate the needs, the constraints and representations of patients on the practice of physical activity.

STEP 1: Patient with prostate cancer

The goal of this questionnaire is to evaluate the sedentary lifestyle of patients.

STEP 2: Patient with prostate cancer and a physical activitySTEP 3: Physical Activity Program

An activity actigraph will use by the patient for a week. It measures the level of physical activity and the sedentary lifestyle of patients.

STEP 2: Patient with prostate cancer and a physical activitySTEP 3: Physical Activity Program

The goal of the peer training will organize once a week for 3 weeks for a patient. After this training, they will have : * Skills in physical activity advice * Knowledge of functional signs (symptoms) * Knowledge to examine heart rate and perceived effort rate

STEP 2: Patient with prostate cancer and a physical activity

During the Physical Activity Program, patients will be supervised by peers and a clubs and sports associations labeled sport-health by Olympic and Sports Committee of the Loire Department. The peer will coach the patient once a week minimum for 3 months.

STEP 3: Physical Activity Program

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Major patient followed for prostate cancer:
  • located or locally advanced,
  • metastatic and / or resistant to castration and chemotherapy.
  • Cancer diagnosed at least 1 year ago
  • Patient affiliated or beneficiary to social security
  • Signed informed consent.
  • In more, step 2 = Patient with Physical Activity for at least 1 year

You may not qualify if:

  • For step 1= In the course of cancer treatment (excluding hormonal therapy)
  • For step 2= Patient in sedentary lifestyle
  • For step 3=
  • In the course of cancer treatment (excluding hormonal therapy)
  • Cardiac or respiratory conditions contraindicating physical activity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

CHU Saint-Etienne

Saint-Etienne, France

Location

ICLN - département de radiothérapie

Saint-Priest-en-Jarez, France

Location

ICLN - Oncologie médicale

Saint-Priest-en-Jarez, France

Location

MeSH Terms

Conditions

Prostatic NeoplasmsMotor Activity

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesBehavior

Study Officials

  • David HUPIN, MD

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This study is composed of 3 dependent steps.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 22, 2018

First Posted

March 7, 2019

Study Start

August 2, 2018

Primary Completion

September 14, 2021

Study Completion

September 14, 2021

Last Updated

February 8, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations